E
EIFO
EIFO is a pre-seed to growth stage investment firm. It has made 53 investments. Average disclosed round size is $29.2M (across 12 rounds with reported amounts).
Portfolio
53
Fund Size
—
Top Stage
Series A
Last 12 Mo
5
Team
CJ
Christoph Junge
Managing Director, Head of Fund Investments
MJ
María Jiménez
Investment Associate
WW
Witold Weglinski
Investment Analyst
AT
Asger Tidemand
Venture Investment
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
60 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| NNutrumami | Pre-Seed | — | Sep 2026 |
 Six Robotics | Unknown | — | Jun 2026 |
| AAisel Health | Pre-Seed | — | Jan 2026 |
 Kvasir | Series A | — | Jan 2026 |
 Chromologics | Unknown | — | Nov 2025 |
 MATR Foods | Series A | — | Oct 2025 |
 MATR Foods | Series A | — | Oct 2025 |
| SSUMM Ingredients | Seed | — | Sep 2025 |
 Interhuman AI | Pre-Seed | — | Aug 2025 |
| PPropane | Pre-Seed | $1.2M | Aug 2025 |
 Quadsat | Series A | — | Jul 2025 |
 Danske Bank | Unknown | — | Jan 2025 |
 Vulcan Energy | Unknown | — | Jan 2025 |
 Orbis Medicines | Series A | — | Jan 2025 |
 ORBIS | Series A | — | Jan 2025 |
 Endless Food Co | Pre-Seed | — | Dec 2024 |
 Antag Therapeutics | Series A | — | Dec 2024 |
 Freya Biosciences | Series A | — | Nov 2024 |
 Aquark Technologies | Seed | — | Sep 2024 |
 Kvantify | Seed | $10.8M | Jul 2024 |
 NIL Technology | Unknown | — | May 2024 |
| FForbion BioEconomy | Unknown | — | Jan 2024 |
 WARD 24/7 | Unknown | — | Jan 2024 |
 Eupry ApS | Series A | — | Jan 2024 |
| Antag Therapeutics | Series A | — | Jan 2024 |
Page 1 of 3
Top Co-Investors
Novo Holdings A/S14 shared
Novo Capital14 shared
Chr. Augustinus Fabrikker6 shared
PSV4 shared
High-Tech Gründerfonds4 shared
European Investment Bank4 shared
Rockstart3 shared
SR One3 shared
Dawn Biopharma3 shared
Versant Ventures3 shared
Planetary Impact Ventures3 shared
Eurazeo3 shared
Atomico3 shared
Prosus Ventures3 shared
2xN3 shared
Lundbeckfonden BioCapital3 shared
The Footprint Firm2 shared
Ananda Impact Ventures2 shared
Gilde Healthcare2 shared
INKEF Capital2 shared
Last updated: 20 October 2026